🇧🇷 DURVALUMAB in Brazil

DURVALUMAB (DURVALUMAB) regulatory status in Brazil.

Marketing authorisation

ANVISA

  • Status: likely_approved

DURVALUMAB in other countries

Same drug, different regulators. Each page below lists the local marketing authorisation, HTA position, pricing, and adverse-event data.

Frequently asked questions

Is DURVALUMAB approved in Brazil?

Yes. ANVISA has authorised it.

Who is the marketing authorisation holder for DURVALUMAB in Brazil?

Marketing authorisation holder not available in our data.